Lexeo Therapeutics (LXEO) Interest Expenses (2022 - 2026)

Lexeo Therapeutics has disclosed Interest Expenses across 5 years of filings, most recently posting $17000.0 for Q1 2026.

• Interest Expenses for Q1 2026 came in at $17000.0, down 39.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $84000.0 (down 34.38% YoY), and the FY2025 annual result was $95000.0, down 30.66% from the prior year.
• Interest Expenses came in at $17000.0 for Q1 2026 at Lexeo Therapeutics, down from $20000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $54000.0 in Q4 2022 to a low of $17000.0 in Q1 2026.
• The 5-year median for Interest Expenses is $35000.0 (2024), against an average of $35800.0.
• Across the five-year window, Interest Expenses soared 79.31% in 2023 and tumbled 40.0% in 2024, its largest moves.
• Lexeo Therapeutics' Interest Expenses stood at $54000.0 in 2022, then slipped by 7.41% to $50000.0 in 2023, then sank by 40.0% to $30000.0 in 2024, then plunged by 33.33% to $20000.0 in 2025, then dropped by 15.0% to $17000.0 in 2026.
• The last three Interest Expenses figures came in at $17000.0 (Q1 2026), $20000.0 (Q4 2025), and $22000.0 (Q3 2025), per Business Quant data.